Amarin Corp Plcuk (AMRN) Total Debt (2010 - 2020)
Amarin Corp Plc\Uk (AMRN) posted quarterly Total Debt of $18.9 million for Q3 2020, down 68.54% year-over-year from $60.0 million in Q4 2019, and down 57.77% quarter-over-quarter from $44.7 million in Q2 2020.
Amarin Corp Plcuk (AMRN) Total Debt (2010 - 2020) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Total Debt for 11 consecutive years, with $18.9 million the latest figure, recorded in Q3 2020.
- In Q3 2020, Total Debt fell 68.54% year-over-year to $18.9 million; the TTM figure through Sep 2020 stood at $18.9 million (down 68.54% YoY), while the FY2019 annual figure was $99.8 million, up 24.25% from the prior year.
- Total Debt fell to $18.9 million in Q3 2020 per AMRN's latest filing, from $44.7 million in the prior quarter.
- Across five years, Total Debt topped out at $156.5 million in Q2 2016 and bottomed at $15.3 million in Q3 2016.
- Historically, Total Debt has averaged $83.8 million across 5 years, with a median of $87.4 million in 2018.
- Annual changes were most pronounced in 2016 — Total Debt slumped 89.1% — and 2017, when it soared 526.96%.
- Amarin Corp Plc\Uk's Total Debt stood at $101.1 million in 2016, then declined by 7.83% to $93.2 million in 2017, then dropped by 13.77% to $80.3 million in 2018, then rose by 24.25% to $99.8 million in 2019, then slumped by 81.08% to $18.9 million in 2020.
- Business Quant data shows AMRN's Total Debt at $18.9 million in Q3 2020, $44.7 million in Q2 2020, and $73.6 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 29.49 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 62.75 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 28.66 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -25.96 Bn |
| 10 | Amarin Corp Plcuk | 5.88 Bn | 5.56 Bn | 14.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 18.89 Mn |
| Jun 30, 2020 | 44.72 Mn |
| Mar 31, 2020 | 73.64 Mn |
| Dec 31, 2019 | 99.83 Mn |
| Sep 30, 2019 | 60.04 Mn |
| Jun 30, 2019 | 68.61 Mn |
| Mar 31, 2019 | 74.30 Mn |
| Dec 31, 2018 | 80.35 Mn |
| Sep 30, 2018 | 84.05 Mn |
| Jun 30, 2018 | 87.44 Mn |
| Mar 31, 2018 | 89.85 Mn |
| Dec 31, 2017 | 93.18 Mn |
| Sep 30, 2017 | 95.76 Mn |
| Jun 30, 2017 | 98.12 Mn |
| Mar 31, 2017 | 99.41 Mn |
| Dec 31, 2016 | 101.10 Mn |
| Sep 30, 2016 | 15.27 Mn |
| Jun 30, 2016 | 156.46 Mn |
| Mar 31, 2016 | 151.43 Mn |
| Dec 31, 2015 | 149.21 Mn |